Skip to content

Design of a Standardized Patient: Mentoring Program for Kidney Transplant Patients

An Innovative Patient-mentoring Program for Kidney Transplant Patients to Reduce Anxiety and Readmission Rates: a Randomized Controlled Trial Leveraging Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03490188
Enrollment
150
Registered
2018-04-06
Start date
2018-08-31
Completion date
2018-12-31
Last updated
2018-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplant; Complications

Brief summary

There is an increasing number in patient's undergoing kidney transplantation in the United States. Furthermore, kidney recipients have high occurrence of 30-day readmissions that leads to high hospital costs and decreased quality of life for transplant recipients. A previous research finds that high levels of post-transplant anxiety is correlated with increased likelihood of 30-day readmissions. The goal of this study is to design and implementat a randomized control trial (RCT) using a standardized post-transplant mentoring program in order to reduce 30-day readmission and post-transplant anxiety among recipients.

Detailed description

In this research, the investigators will seek to examine the efficacy of using former patients as mentors to newly transplanted patients and its relationship with patient anxiety following discharge as well as the prevention of 30-day readmissions for kidney transplant recipients. The primary hypothesis is that the treatment group of patients who undergo a targeted mentorship program will be better compliant with the discharge instructions and will perform better when compared to the control group who undergoes current routine post-transplantation care. Evidence from this experiment can help advance our understanding of patient-engagement in the continuity of care delivery, decrease patient readmission rates, and improve overall cost utilization. Methods: The investigators will conduct a single institution randomized control trial assigning patients getting discharged after a kidney transplant to a treatment group that involves a 30-day mentoring initiative by former transplant patients, and comparing the efficacy with a similar control group. The overall study period will be divided into the following sections, summarized in Figure 1.

Interventions

BEHAVIORALDischarge Mentoring

Phone Conversations on the importance of complying to discharge instructions delivered before discharge

Sponsors

Ohio State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

A single institution randomized control trial assigning patients getting discharged after a kidney transplant to treatment and control group

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* any patient who received a kidney transplantation, deceased or living donor, during the study period.

Exclusion criteria

* anyone younger than 18 years old or older than 70 years old.

Design outcomes

Primary

MeasureTime frame
30-day readmissions30-days

Secondary

MeasureTime frameDescription
Post Transplant Anxiety1 Day of Discharge and 30-days after dischargeState-Trait Anxiety Inventory (STAI) for Adults
Preventable Re-admissions30-days after day of dischargeRe admissions due to missed labs or medications as measured by time of readmission for any readmission that was deemed preventable by physiologic laboratory data, reason for readmission, and primary complaint determined by trained kidney transplantation nurses

Countries

United States

Contacts

Primary ContactKarla Zadnik, OD PhD
irbinfo@osu.edu614 688 8457

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026